GOCO vs ABEO โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
ABEO Captures Institutional Edge (3โ1 Pillars ยท 10โ0 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Abeona Therapeutics Inc. Common Stock (ABEO) driven by superior Valuation, Growth & Margin, Momentum & Technical while GOCO counters with relative strength in Options & Structure. Fundamentally, GOCO trades at N/M Forward P/E with -292.0% operating margin (-94.6% YoY revenue) versus ABEO at 18.7x Forward P/E and -186.1% operating margin (+2745.0% YoY). In options structure, GOCO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABEO sits in BREAKDOWN (27th %ile IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | GOCO | ABEO | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $8.5M | $149.2M | Larger Scale | ABEO |
| Trailing P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Forward P/E Ratio Valuation | N/M | 18.7x | Lower Multiple | ABEO |
| Revenue Growth (YoY) Growth | -94.6% | +2745.0% | Higher Growth | ABEO |
| Operating Margin (TTM) Profitability | -292.0% | -186.1% | Higher Margin | ABEO |
| Net Profit Margin Profitability | -189.7% | -160.3% | Higher Margin | ABEO |
| Return on Equity (ROE) Capital Efficiency | -289.9% | -42.1% | Higher ROE | ABEO |
| 52-Week Range Position Momentum | 0% ($0โ$7) | 9% ($2โ$8) | Stronger Trend | ABEO |
| Beta / 30D Volatility Risk Regime | 2.15ฮฒ ยท 201% Vol | 0.60ฮฒ ยท 145% Vol | Lower Realized Risk | ABEO |
| Unified Institutional Score Composite Signal | 42.9 / 100 (HOLD) | 44.1 / 100 (HOLD) | Higher Composite | ABEO |